Arcutis Biotherapeutics Inc

NASDAQ:ARQT   3:59:54 PM EDT
24.82
-0.04 (-0.16%)
Earnings Announcements

Arcutis Announces Second Quarter 2022 Financial Results And Provides Business Update

Published: 08/04/2022 20:58 GMT
Arcutis Biotherapeutics Inc (ARQT) - Arcutis Announces Second Quarter 2022 Financial Results and Provides Business Update.
Q2 Loss per Share $1.31.
Cash, Cash Equivalents, Restricted Cash, and Marketable Securities Were $283.4 Million As of June 30, 2022.
Revenue is expected to be $0.83 Million
Adjusted EPS is expected to be -$1.41

Next Quarter Revenue Guidance is expected to be $3.05 Million
Next Quarter EPS Guidance is expected to be -$1.43

More details on our Analysts Page.